A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C ] encorafenib in healthy male subjects
1. 系统已在2025-08-18 10:54:40对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1002/prp2.1140
文献链接: https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/prp2.1140
其他信息:
出版社: Wiley
作者: Lance Wollenberg; Erik Hahn; Jason Williams; Kevin Litwiler